Skip to content

Medpace Holdings, Inc. MEDP Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$12.09M+3,405%
Veeva Systems logo
Veeva SystemsVEEV
$2.94M-92.8%
Arrowhead Research logo
Arrowhead ResearchARWR
$46.83M
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$22.59M
Guardant Health logo
Guardant HealthGH
$3.65M+375%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$5.5M+120%

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s stock issuance proceeds?
Medpace Holdings, Inc. (MEDP) reported stock issuance proceeds of $12.67M in Q1 2026.
How has Medpace Holdings, Inc.'s stock issuance proceeds changed year-over-year?
Medpace Holdings, Inc.'s stock issuance proceeds decreased by 51.1% year-over-year, from $25.93M to $12.67M.
What is the long-term trend for Medpace Holdings, Inc.'s stock issuance proceeds?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s stock issuance proceeds has grown at a 34.1% compound annual growth rate (CAGR), from $17.64M to $57M.
What does stock issuance proceeds mean?
Cash received by the company from issuing new shares or employees exercising stock options.
How do you interpret stock issuance proceeds?
Higher values indicate significant employee participation in equity plans or capital raising, which can lead to share dilution.
How does stock issuance proceeds compare across companies?
Standard across all public companies with equity-based compensation programs.